483
Supriya Lifescience LimitedSupriya Lifescience Limited – FDA 483, Feb 6, 2026
Record Details
During an FDA inspection from February 2-6, 2026, Supriya Lifescience LTD. in Ratnagiri, India, was cited for failing to demonstrate that its manufacturing process can reproducibly produce intermediates and APIs meeting predetermined quality attributes. This critical issue is highlighted by multiple reprocessed batches and open Out of Specification investigations due to increased impurity levels, indicating significant concerns with process validation and product quality.
View Company Profile
ID · f8990dae-dd91-4e78-a752-c690c171356d
Other documents for Supriya Lifescience Limited
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.